Nuo Therapeutics, Inc.: Form 10-Q for the period ended Mar 31, 2019
Filed with the SEC on May 20, 2019 and accepted by EDGAR at May 20, 2019, 21:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-01-01 to 2019-03-31 | $39.2k | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2019-01-01 to 2019-03-31 | $28.7k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2019-01-01 to 2019-03-31 | $10.5k | us-gaap:GrossProfit |
| Research and development | 3 months2019-01-01 to 2019-03-31 | $94.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-01-01 to 2019-03-31 | −$611.8k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2019-01-01 to 2019-03-31 | −$679.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-01-01 to 2019-03-31 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-01-01 to 2019-03-31 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-01-01 to 2019-03-31 | 23,722,400 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2019-01-01 to 2019-03-31 | −$451.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2019-03-31 | $185.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-03-31 | $377.8k | us-gaap:AssetsCurrent |
| Total assets | At period end2019-03-31 | $461.4k | us-gaap:Assets |
| Total liabilities | At period end2019-03-31 | $1.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-03-31 | −$711.9k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-19-010509. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.